Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Targeting integrin and integrin signaling in treating thrombosis.

Estevez B, Shen B, Du X.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):24-9. doi: 10.1161/ATVBAHA.114.303411. Epub 2014 Sep 25. Review. Erratum in: Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):e18.

2.

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

Desai PC, Brittain JE, Jones SK, McDonald A, Wilson DR, Dominik R, Key NS, Parise LV, Ataga KI.

Thromb Res. 2013 Sep;132(3):341-5. doi: 10.1016/j.thromres.2013.08.002. Epub 2013 Aug 8.

3.

Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Bledzka K, Smyth SS, Plow EF.

Circ Res. 2013 Apr 12;112(8):1189-200. doi: 10.1161/CIRCRESAHA.112.300570. Review.

4.
5.

Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin.

Sivaraman B, Latour RA.

Biomaterials. 2011 Aug;32(23):5365-70. doi: 10.1016/j.biomaterials.2011.04.011. Epub 2011 May 6.

6.

The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen.

Sánchez-Cortés J, Mrksich M.

Chem Biol. 2009 Sep 25;16(9):990-1000. doi: 10.1016/j.chembiol.2009.08.012.

7.

Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells.

Pathak A, Zhao R, Huang J, Stouffer GA.

Cardiovasc Diabetol. 2008 Dec 23;7:36. doi: 10.1186/1475-2840-7-36.

8.

Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells.

Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, Matsunaga TO, Ferrara KW.

Mol Imaging. 2004 Apr;3(2):125-34.

Supplemental Content

Support Center